Candidemia in a tertiary hospital in northeastern Brazil;Candidemia em hospital terciário do nordeste do Brasil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 4, 2008, Pages 394-398

  Hinrichsen, Sylvia Lemos ^a,e   Falcão, Érika ^b   Vilella, Tatiana Aguiar Santos ^a   Colombo, Arnaldo Lopes ^c   Nucci, Márcio ^d   Moura, Líbia ^a   Rêgo, Leandro ^a   Lira, Conceição ^a   Almeida, Luciano ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Departamento de Microbiologia   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e NONE   (Brazil)

Author keywords

Candida non albicans; Candida species; Candidemia; Incidence

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CULTURE; BRAZIL; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HOSPITALS, GENERAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

CANDIDA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 56049117241     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000400014     Document Type: Article

References (24)

1. Alexander JW, Boyce ST, Babcock GF. The process of microbial translocation. Annals of Survey 212: 496-510, 1990.
2. Almirante B, Rodrigues D, Park BJ. Epidemiology and predictor of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. Journal of Clinical Microbiology 43: 1829-1835, 2005.
3. Antunes AGV, Pasqualotto AC, Diaz MC, Azevedo PA, Severo LC. Candidemia in a Brazilian Tertiary Care Hospital: Species, Distribution and Antifungal Susceptibility Patterns. Revista do Instituto de Medicina Tropical de São Paulo 46: 239-241, 2004.
4. Aquino VR, Lunardi WL, Goldmani LZ, Barth AL. Prevalence, Susceptibility Profile for Fluconazol and Risk Factors for Candidemia in a Tertiary Hospital in Southern Brazil. The Brazilian Journal of Infectious Diseases 9: 411-418, 2005.
5. Barberino MG, Silva N, Rebouças C, Barreiro K, Alcântara AP, Netto EM, Albuquerque L, Brites C. Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: a case-control study. Brazilian Journal of Infectious Diseases 10: 36-40, 2006.
6. Brito LR, Guimarães T, Nucci M, Rosas RC, Almeida LP, Matta DA, Colombo AL. Clinical and microbiological aspects of candidemia due to C. parapsilosis in Brazilian tertiary care hospitals. Medical Mycology 44: 261-266, 2006.
7. Colombo AL. Epidemiology and treatment of hematogenous candidiasis: a Brazilian prospective. Brazilian Journal Infectious Diseases 4: 113-118, 2000.
8. Colombo AL, Guimarães T. Epidemiology of Hematogenous Infections due to Candida spp. Revista da Sociedade Brasileira de Medicina Tropical 36: 599-607, 2003.
9. Colombo AL, Nucci M, Park BJ, Nouer AS, Arthington-Skaggs B, Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. Journal of Clinical Microbiology 44: 2816-2823, 2006.
10. Edmond MB, Wallace SE, McClish DK, Phaller MA, Jones RN, Wenzel RP. Nosocomial Bloodstream Infections in United State Hospitals: A Three-Year Analysis. Clinical Infectious Diseases 29: 239-244, 1999.
11. França JCB, Ribeiro CEL, Queiroz-Telles F. Candidemia em um hospital terciário brasileiro: incidência, freqüência das diferentes espécies, fatores de risco e suscetibilidade aos antifúngicos. Revista da Sociedade Brasileira de Medicina Tropical 41: 23-28, 2008.
12. Kuse ER, Chetchotisakd P, Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369: 1519-1527, 2007.
13. Morgan J. Global trends in candidemia: review of reports from 1995-2005. Clinical Infectious Disease Report 7: 429-439, 2005.
14. Nucci M, Colombo AL. Risk Factors for Breakthrough Candidemia. European Journal Microbiology Infectious Diseases 27: 209-211, 2002.
15. Nucci M, Silveira MI, Spector N, Silveira F, Velasco E, Akiti T, Barreiros G, Derossi A, Colombo AL, Pulcheri W. Risk Factors for Death Among Cancer Patients with Fungemia. Clinical Infectious Diseases 27: 107-111, 1998.
16. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE. For the NIAID Mycoses Study Group. A Prospective Observational Study of Candidemia. Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients. Clinical Infectious Diseases 37: 634-643, 2003.
17. Pasqualotto AC, Nedel WL, Machado TS, Severo LC. A 9-year Study Comparing Risk Factors and the outcome of Pediatrics and Adults with Nosocomial Candidemia. Mycopathologia 160: 111-116, 2005.
18. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological Factors Influencing of Nosocomial Bloodstream Infections: A 6-Year Validated, Population-Based Model Clinical Infectious Diseases 24: 1068-1078, 1997.
19. Rex JH, Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clinical Infectious Diseases 32: 1191-1200, 2001.
20. Viudes A, Peman J, Canton E, Úbeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a Terciary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death. European Journal of Microbiology Infectious Diseases 21: 767-774, 2002.
21. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia. The attributable mortality and excess length of stay. Archives of Internal Medicine 148: 2642-2645, 1998.
22. Wingard JR. Importance of Candida species other than Candida albicans as pathogens in oncology patients. Clinical Infectious Diseases 20: 115-125, 1995.
23. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24.179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 39:309-317, 2004.
24. Zeichnner LO, Pappas PG. Invasive candidiases in the intensive care unit. Journal of Critical Care Medicine 34: 857-863, 2006.